TrialCancer science2021

Phase II study of E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T-cell lymphoma.

Hidetsugu Kawai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.